Generate Biomedicines, Inc. ($GENB)
Filing Information
| Accession Number | 0001193125-26-085855 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 2, 2026 |
| Document | View SEC Filing |
Transactions
19
Total Shares
87,766,383
Total Value
$75,000,000.00
P&L
-23.2% ($17,404,685.19)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Mar 2, 2026 | Conversion | 12,723,940 | โ | โ | 12,723,940 | Indirect | By Flagship Pioneering Fund VI, L.P. | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Conversion | 13,702,224 | โ | โ | 13,702,224 | Indirect | By Flagship Pioneering Fund VII, L.P. | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Conversion | 987,491 | โ | โ | 987,491 | Indirect | By Nutritional Health LTP Fund, L.P. | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Conversion | 2,777,752 | โ | โ | 2,777,752 | Indirect | By Flagship Pioneering Special Opportunities Fund II, L.P. | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Conversion | 2,777,752 | โ | โ | 2,777,752 | Indirect | By FPN II, L.P. | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Purchase | 1,562,500 | $16.00 | $25,000,000.00 | 15,264,724 | Indirect | By Flagship Pioneering Fund VII, L.P. | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Purchase | 1,562,500 | $16.00 | $25,000,000.00 | 4,340,252 | Indirect | By FPN II, L.P. | View Details | |
Director | Common Stock | โ | Mar 2, 2026 | Purchase | 1,562,500 | $16.00 | $25,000,000.00 | 1,562,500 | Indirect | By Pioneering Medicines 02, LLC | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Feb 26, 2026 | Grant/Award | 29,561 | $0.00 | $0.00 | 29,561 | Direct | โ | View Details | |
Director | Series A Preferred Stock | Derivative | Mar 2, 2026 | Conversion | 18,483,785 | $0.00 | $0.00 | 0 | Indirect | By Flagship Pioneering Fund VI, L.P. | View Details | |
Director | Series A Preferred Stock | Derivative | Mar 2, 2026 | Conversion | 17,016,215 | $0.00 | $0.00 | 0 | Indirect | By Flagship Pioneering Fund VII, L.P. | View Details | |
Director | Series A Preferred Stock | Derivative | Mar 2, 2026 | Conversion | 1,500,000 | $0.00 | $0.00 | 0 | Indirect | By Nutritional Health LTP Fund, L.P. | View Details | |
Director | Series B Preferred Stock | Derivative | Mar 2, 2026 | Conversion | 843,881 | $0.00 | $0.00 | 0 | Indirect | By Flagship Pioneering Fund VI, L.P. | View Details | |
Director | Series B Preferred Stock | Derivative | Mar 2, 2026 | Conversion | 1,265,822 | $0.00 | $0.00 | 0 | Indirect | By Flagship Pioneering Fund VII, L.P. | View Details | |
Director | Series B Preferred Stock | Derivative | Mar 2, 2026 | Conversion | 2,953,586 | $0.00 | $0.00 | 0 | Indirect | By Flagship Pioneering Special Opportunities Fund II, L.P. | View Details | |
Director | Series B Preferred Stock | Derivative | Mar 2, 2026 | Conversion | 2,109,704 | $0.00 | $0.00 | 0 | Indirect | By FPN II, L.P. | View Details | |
Director | Series C Preferred Stock | Derivative | Mar 2, 2026 | Conversion | 2,531,644 | $0.00 | $0.00 | 0 | Indirect | By Flagship Pioneering Fund VII, L.P. | View Details | |
Director | Series C Preferred Stock | Derivative | Mar 2, 2026 | Conversion | 1,265,822 | $0.00 | $0.00 | 0 | Indirect | By Flagship Pioneering Special Opportunities Fund II, L.P. | View Details | |
Director | Series C Preferred Stock | Derivative | Mar 2, 2026 | Conversion | 2,109,704 | $0.00 | $0.00 | 0 | Indirect | By FPN II, L.P. | View Details |